Loading...
Dernières publications
-
Hélène Bricout, Marie‐cécile Levant, Nada Assi, Pascal Crepey, Alexandre Descamps, et al.. The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season. Clinical Microbiology and Infection, 2024, 30 (12), pp.1592-1598. ⟨10.1016/j.cmi.2024.08.012⟩. ⟨hal-04698967⟩
-
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1), pp.1049. ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
93
Notices
62
Mots clés
HIV
COVID-19
Cohort study
Hospitalisations
Covid-19
Epidemiology
Administrative claims
Dialysis
Vaccine safety and efficacy
Adults
Boys
ANTIRETROVIRAL THERAPY
Clinical practice
France
AIDS
Adverse effects
Co-morbidities
Virology
Efficacy
DMD
Breakthrough infections
Vaccine effectiveness
Cohort
HPV vaccine
C-type lectin receptor
Antiviral
Booster response
Confidence
Cohort studies
Conjugate pneumococcal vaccine
Attitudes
CERVICOVAGINAL SECRETIONS
Immunocompromised
Clinical skills
Incidence
COVID-19 mRNA vaccine
Biomarkers
Adenoviral vector
Coronavirus
Sleep
Risk factors
Awareness
Adjuvant
Coadministration
Influenza-like illness
Hesitancy
Healthcare workers
Catch-up
Bayes' theorem
Care management
Community-acquired AKI
Determinants
1790GAHB F
AON
COCONEL cohort surveys
Antiretroviral therapy
Immunization
Antiviral agents
Attitude
Influenza vaccines
SARS-CoV-2
Misinformation
Conditional marketing authorization
Antiviral therapy
Vaccination
AstraZeneca vaccine
Clinical research
Effectiveness
Innate immunity
Country income
Influenza
Europe
Chemotherapy
Cancer
Cost of illness
Vaccine acceptance
Vaccine hesitancy
Respiratory syncytial virus
Calcium phosphorus evaluation
Covid 19
Assay
Vaccine
Vaccines
Data sharing
Elderly
Internet
COVID-19 vaccines
Attitudes of health personnel
Acute kidney injury
Immunogenicity
Practices
Attitude to health
Alpha variant
Cystic fibrosis
Older adults
Chronic kidney disease
Covidom
Specific populations
B-lymphocytes
Clinical trials